Ed Kenkel is currently the Finance Director for the Johnson & Johnson (J&J) California Innovation Center where he provides finance leadership in evaluating and structuring licenses and collaborations with potential partners. Prior to his role at J&J Innovation, Ed was the Senior Manager of Financial Reporting for Janssen Alzheimer Immunotherapy. In this position, Ed provided financial reporting leadership for a unique legal entity within J&J that included an independent Board of Directors, a minority shareholder, and a large partnership with Pfizer, Inc. Prior to this role, Ed held several roles in commercial finance at Janssen North America Pharmaceuticals. Before joining J&J, Ed worked for BAE Systems in Johnson City, NY where he held a variety of roles in their Finance Leadership Development Program. Ed holds a BS in Business Administration from Ithaca College and an MBA from San Francisco State University.